TPIDB > Outstanding PI
Outstanding PI
2026 Psychiatry
2026 Medical Oncology
2026 Infectious Disease
2026 Obstetrics and Gynecology
2026 Nephrology
2026 Orthopedics
2026 Thoracic Surgery
2026 Thoracic Medicine
2026 Neurology
2026 Gastroenterological Surgery
2026 Digestive System
2026 Family Medicine
2026 Rheumatology
2026 Urology
2026 Hematology & Oncology
2026 Otolaryngology
2026 General Surgery
2026 Cardiovascular Diseases
2026 Endocrinology
2026 Pediatrics
Highlights
Number of Clinical Trials 74
1. Global leading PI: Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022, doi:10.1016/s0140-6736(22)00313-0.
2. Great contribution to Pediatric Infectious Diseases
3. Early phase small-molecule drug/vaccine development
ChiuCheng-Hsun
- Linkou Chang Gung Medical Foundation
- CHANGHUA CHRISTIAN HOSPITAL
-
Division of Pediatrics
未分科
Division of Infectious Disease
Highlights
Number of Clinical Trials 69
JongYuh-Jyh
- Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
-
Division of Pediatrics
未分科
Highlights
Number of Clinical Trials 26
